Portfolio company
Synteny Biotechnology
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops generative AI platforms to design programmable protein therapeutics and precision immunology treatments for biotechnology researchers and pharmaceutical developers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Synteny
This company develops AI-based bioinformatic solutions and programmable protein therapeutics to help pharmaceutical and biotechnology firms discover treatments for immune-driven diseases.
Generate Biomedicine
This company develops protein-based therapeutics using a generative artificial intelligence platform for pharmaceutical partners and biotechnology firms.
Evozyne
The company creates synthetic therapeutic proteins using generative artificial intelligence for pharmaceutical and biotechnology organisations to treat immune-mediated diseases and genetic disorders.
Synthekine
This company develops engineered cytokine therapeutics and protein engineering platforms for patients with cancer and autoimmune or inflammatory diseases.
Aikium
This company develops artificial intelligence and synthetic biology platforms to design and screen protein therapeutic libraries for biotechnology and pharmaceutical partners.
310.ai
This company develops generative artificial intelligence models to design novel proteins and biomolecules for pharmaceutical and biotechnology organisations.
Profluent Bio
Profluent Bio develops generative artificial intelligence models to design novel functional proteins for biopharmaceutical companies and industrial partners.
Profluent
This company develops generative artificial intelligence models to design novel proteins and gene editors for pharmaceutical, biotechnology and agricultural organisations.